From hardcore peptide biochemist to translational scientist, it’s been an unconventional journey for Jennifer Van Eyk, Director of the Advanced Clinical Biosystems Research Institute at Cedars-Sinai Medical Center, Los Angeles. Here, Jenny tells us what she’s learnt along the way.

Cancer is incredibly complex, posing enormous challenges beyond the biological field. Taking a multi-omic approach can help us make sense of this diverse set of diseases – and, ultimately, allow us to better understand ourselves as human beings.

The newest addition to the popular ‘10 ways to…’ series of educational papers provides practical guidance on developing high performance suspension products with enhanced consumer appeal. ‘10 ways to...control rheology by changing particle properties’ explores how controlling particle characteristics, such as particle size distribution, concentration and zeta potential, enables formulators to engineer suspension performance. Suspensions are used in the formulation of a wide range of every day products from medicines, drinks and foodstuffs to paints, inks and coatings. This paper is therefore valuable to formulators working across a wide range of industries.

Sitting Down With... Jessica Prenni, Director of Research Core Facilities, Director of Proteomics & Metabolomics Facility, Colorado State University, USA.

Are you ready for the “unthinkable” – your laboratory computer systems suffering a titanic failure? Disaster recovery plans are crucial insurance against the unexpected.

The latest advances in the widely used technique of size exclusion chromatography (SEC) break new ground in terms of accuracy and sensitivity. This article assesses the information provided by multi-detector SEC and the potential benefits of recent innovations for polymeric food additive characterization.

Is now the right time for HPLC’s diminutive cousin to make a comeback in routine analysis?

When it comes to microsampling for quantitative bioanalysis, the devil is certainly in the details. But we should learn from our mistakes – not retreat back into convention.

Detecting and controlling mutagenic impurities in pharmaceuticals is challenging. What is ICH M7 and what do you need in your analytical toolbox?

When disruptive technology comes along, it can be hard to defend the technique under attack for some applications – even if we have embraced it for decades.